Peptidomimetics and Their Applications for Opioid Peptide Drug Discovery

Biomolecules. 2022 Sep 5;12(9):1241. doi: 10.3390/biom12091241.

Abstract

Despite various advantages, opioid peptides have been limited in their therapeutic uses due to the main drawbacks in metabolic stability, blood-brain barrier permeability, and bioavailability. Therefore, extensive studies have focused on overcoming the problems and optimizing the therapeutic potential. Currently, numerous peptide-based drugs are being marketed thanks to new synthetic strategies for optimizing metabolism and alternative routes of administration. This tutorial review briefly introduces the history and role of natural opioid peptides and highlights the key findings on their structure-activity relationships for the opioid receptors. It discusses details on opioid peptidomimetics applied to develop therapeutic candidates for the treatment of pain from the pharmacological and structural points of view. The main focus is the current status of various mimetic tools and the successful applications summarized in tables and figures.

Keywords: analgesic drugs; bioavailability; locally constrained peptides; opioid receptors; peptide backbone modifications; peptidomimetic.

Publication types

  • Review

MeSH terms

  • Analgesics, Opioid / metabolism
  • Analgesics, Opioid / pharmacology
  • Analgesics, Opioid / therapeutic use
  • Drug Discovery
  • Opioid Peptides* / chemistry
  • Opioid Peptides* / pharmacology
  • Opioid Peptides* / therapeutic use
  • Peptidomimetics* / pharmacology
  • Peptidomimetics* / therapeutic use
  • Receptors, Opioid

Substances

  • Analgesics, Opioid
  • Opioid Peptides
  • Peptidomimetics
  • Receptors, Opioid

Grants and funding

This research received no external funding.